Clinical Trial Update: (68)Ga-FAPI PET/CT in Patients With ANCA-associated Vasculitis

View source ↗

Summary

A clinical trial evaluating the use of Gallium-68 labeled FAPI PET/CT imaging for ANCA-associated vasculitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis

Drugs mentioned

• (68)Ga-FAPI PET/CT tracer (Gallium-68 labeled fibroblast activation protein inhibitor imaging agent)

Snippet

Sponsor: Ruijin Hospital | Conditions: ANCA-associated Vasculitis | Status: RECRUITING